Recent trends in the delivery of RNA drugs: Beyond the liver, more than vaccine.
Eur J Pharm Biopharm.
2024 Apr;197:114203. doi: 10.1016/j.ejpb.2024.114203. Epub 2024 Feb 1. Review. PubMed PMID:
38302049; PubMed Central PMCID:
PMC10947810.
Delivery of STING agonists for cancer immunotherapy.
Curr Opin Biotechnol.
2024 Mar 9;87:103105. doi: 10.1016/j.copbio.2024.103105. [Epub ahead of print] Review. PubMed PMID:
38461748; NIHMSID:NIHMS1969996.
Long-Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy.
Small.
2024 Mar;20(10):e2306479. doi: 10.1002/smll.202306479. Epub 2023 Nov 8. PubMed PMID:
37940612; PubMed Central PMCID:
PMC10939919.
Systemic Delivery of Paclitaxel by Find-Me Nanoparticles Activates Antitumor Immunity and Eliminates Tumors.
ACS Nano.
2024 Jan 30;18(4):3681-3698. doi: 10.1021/acsnano.3c11445. Epub 2024 Jan 16. PubMed PMID:
38227965; NIHMSID:NIHMS1982719.
RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin-ferroptosis axis.
Cell Death Dis.
2023 Nov 30;14(11):786. doi: 10.1038/s41419-023-06302-0. PubMed PMID:
38036507; PubMed Central PMCID:
PMC10689482.
A timescale-guided microfluidic synthesis of tannic acid-Fe(III) network nanocapsules of hydrophobic drugs.
J Control Release.
2023 May;357:484-497. doi: 10.1016/j.jconrel.2023.04.024. Epub 2023 Apr 21. PubMed PMID:
37068522; PubMed Central PMCID:
PMC10225907.
Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells.
J Immunother Cancer.
2023 Feb;11(2). doi: 10.1136/jitc-2022-005862. PubMed PMID:
36792123; PubMed Central PMCID:
PMC9933761.
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery.
Adv Drug Deliv Rev.
2023 Jan;192:114635. doi: 10.1016/j.addr.2022.114635. Epub 2022 Nov 26. Review. PubMed PMID:
36503885; PubMed Central PMCID:
PMC9812987.
Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam.
J Control Release.
2023 Jan;353:823-831. doi: 10.1016/j.jconrel.2022.12.019. Epub 2022 Dec 17. PubMed PMID:
36521690.
Size optimization of carfilzomib nanocrystals for systemic delivery to solid tumors.
J Control Release.
2022 Dec;352:637-651. doi: 10.1016/j.jconrel.2022.10.041. Epub 2022 Nov 5. PubMed PMID:
36349616; PubMed Central PMCID:
PMC9737058.
An Expanding Role of 2',3'-Cyclic Nucleotide Monophosphates in Bacteria.
ACS Cent Sci.
2022 Nov 23;8(11):1480-1483. doi: 10.1021/acscentsci.2c01184. Epub 2022 Nov 15. PubMed PMID:
36439309; PubMed Central PMCID:
PMC9686210.
Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections.
Pharm Res.
2022 Jun;39(6):1085-1114. doi: 10.1007/s11095-022-03188-z. Epub 2022 Feb 10. PubMed PMID:
35146592; PubMed Central PMCID:
PMC8830998.
A single local delivery of paclitaxel and nucleic acids via an immunoactive polymer eliminates tumors and induces antitumor immunity.
Proc Natl Acad Sci U S A.
2022 May 31;119(22):e2122595119. doi: 10.1073/pnas.2122595119. Epub 2022 May 24. PubMed PMID:
35609195; PubMed Central PMCID:
PMC9295735.
Evaluation of Phenol-Substituted Diphyllin Derivatives as Selective Antagonists for Ebola Virus Entry.
ACS Infect Dis.
2022 May 13;8(5):942-957. doi: 10.1021/acsinfecdis.1c00474. Epub 2022 Mar 31. PubMed PMID:
35357134; PubMed Central PMCID:
PMC9112336.
Mechanistic Studies and In Vivo Efficacy of an Oxadiazole-Containing Antibiotic.
J Med Chem.
2022 May 12;65(9):6612-6630. doi: 10.1021/acs.jmedchem.1c02034. Epub 2022 Apr 28. PubMed PMID:
35482444; PubMed Central PMCID:
PMC9124606.
Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy.
J Control Release.
2022 May;345:586-600. doi: 10.1016/j.jconrel.2022.03.045. Epub 2022 Mar 26. Review. PubMed PMID:
35351528; PubMed Central PMCID:
PMC9133138.
Comparative Studies to Uncover Mechanisms of Action of N-(1,3,4-Oxadiazol-2-yl)benzamide Containing Antibacterial Agents.
ACS Infect Dis.
2022 Apr 8;8(4):865-877. doi: 10.1021/acsinfecdis.1c00613. Epub 2022 Mar 17. PubMed PMID:
35297603; PubMed Central PMCID:
PMC9188027.
Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis.
Sci Adv.
2021 Aug;7(32). doi: 10.1126/sciadv.abj1577. Print 2021 Aug. PubMed PMID:
34362742; PubMed Central PMCID:
PMC8346222.
Starving Bacteria of Iron: A Potential Strategy to Disperse Bacterial Biofilms.
J Med Chem.
2021 Jun 10;64(11):7272-7274. doi: 10.1021/acs.jmedchem.1c00749. Epub 2021 May 14. PubMed PMID:
33988992; PubMed Central PMCID:
PMC9110258.
Nanosac, a Noncationic and Soft Polyphenol Nanocapsule, Enables Systemic Delivery of siRNA to Solid Tumors.
ACS Nano.
2021 Mar 23;15(3):4576-4593. doi: 10.1021/acsnano.0c08694. Epub 2021 Mar 1. PubMed PMID:
33645963; PubMed Central PMCID:
PMC8023695.
The assembly of β-barrel membrane proteins by BAM and SAM.
Mol Microbiol.
2021 Mar;115(3):425-435. doi: 10.1111/mmi.14666. Epub 2020 Dec 23. Review. PubMed PMID:
33314350; PubMed Central PMCID:
PMC8608283.
Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities.
J Control Release.
2021 Feb 10;330:438-460. doi: 10.1016/j.jconrel.2020.12.025. Epub 2020 Dec 31. Review. PubMed PMID:
33352244.
Engineering microenvironment of biodegradable polyester systems for drug stability and release control.
Ther Deliv.
2021 Jan;12(1):37-54. doi: 10.4155/tde-2020-0113. Epub 2021 Jan 5. Review. PubMed PMID:
33397135.
SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.
J Biol Chem.
2021 Jan-Jun;296:100103. doi: 10.1074/jbc.RA120.016148. Epub 2020 Nov 27. PubMed PMID:
33214224; PubMed Central PMCID:
PMC7832013.
Multiplexed Tissue Tomography.
Methods Mol Biol.
2021;2350:77-93. doi: 10.1007/978-1-0716-1593-5_6. PubMed PMID:
34331280; PubMed Central PMCID:
PMC8559895.
Structure Determination of Membrane Proteins Using X-Ray Crystallography.
Methods Mol Biol.
2021;2302:101-136. doi: 10.1007/978-1-0716-1394-8_7. PubMed PMID:
33877625; PubMed Central PMCID:
PMC8633976.
Antibacterial nanotruffles for treatment of intracellular bacterial infection.
Biomaterials.
2020 Dec;262:120344. doi: 10.1016/j.biomaterials.2020.120344. Epub 2020 Aug 29. PubMed PMID:
32905902.
Ultrapotent Inhibitor of Clostridioides difficile Growth, Which Suppresses Recurrence In Vivo.
J Med Chem.
2020 Oct 22;63(20):11934-11944. doi: 10.1021/acs.jmedchem.0c01198. Epub 2020 Oct 6. PubMed PMID:
32960605; PubMed Central PMCID:
PMC9064041.
The first DEP domain of the RhoGEF P-Rex1 autoinhibits activity and contributes to membrane binding.
J Biol Chem.
2020 Sep 4;295(36):12635-12647. doi: 10.1074/jbc.RA120.014534. Epub 2020 Jul 13. PubMed PMID:
32661198; PubMed Central PMCID:
PMC7476721.
Bioresorbable, Miniaturized Porous Silicon Needles on a Flexible Water-Soluble Backing for Unobtrusive, Sustained Delivery of Chemotherapy.
ACS Nano.
2020 Jun 23;14(6):7227-7236. doi: 10.1021/acsnano.0c02343. Epub 2020 May 18. PubMed PMID:
32401016; PubMed Central PMCID:
PMC8279902.
Topical application of zwitterionic chitosan suppresses neutrophil-mediated acute skin inflammation.
Int J Biol Macromol.
2020 May 6;. doi: 10.1016/j.ijbiomac.2020.05.017. [Epub ahead of print] PubMed PMID:
32387602; PubMed Central PMCID:
PMC7644656.
Carfilzomib Delivery by Quinic Acid-Conjugated Nanoparticles: Discrepancy Between Tumoral Drug Accumulation and Anticancer Efficacy in a Murine 4T1 Orthotopic Breast Cancer Model.
J Pharm Sci.
2020 Apr;109(4):1615-1622. doi: 10.1016/j.xphs.2020.01.008. Epub 2020 Jan 13. PubMed PMID:
31945310; PubMed Central PMCID:
PMC7096246.
Sustained Delivery of Carfilzomib by Tannic Acid-Based Nanocapsules Helps Develop Antitumor Immunity.
Nano Lett.
2019 Nov 13;19(11):8333-8341. doi: 10.1021/acs.nanolett.9b04147. Epub 2019 Nov 4. PubMed PMID:
31657935; PubMed Central PMCID:
PMC6885327.
In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate.
Biomaterials.
2019 Oct;217:119296. doi: 10.1016/j.biomaterials.2019.119296. Epub 2019 Jun 21. PubMed PMID:
31254934; PubMed Central PMCID:
PMC6670295.
Development of Liposomal Gemcitabine with High Drug Loading Capacity.
Mol Pharm.
2019 Jul 1;16(7):2858-2871. doi: 10.1021/acs.molpharmaceut.8b01284. Epub 2019 Jun 14. PubMed PMID:
31136710; PubMed Central PMCID:
PMC6662591.
Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation.
J Control Release.
2019 May 28;302:148-159. doi: 10.1016/j.jconrel.2019.04.006. Epub 2019 Apr 4. PubMed PMID:
30954620; PubMed Central PMCID:
PMC6638563.
Magnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer.
Mol Pharm.
2019 May 6;16(5):1864-1873. doi: 10.1021/acs.molpharmaceut.8b01148. Epub 2019 Apr 10. PubMed PMID:
30916974; PubMed Central PMCID:
PMC6542733.
Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations.
Nano Lett.
2019 Mar 13;19(3):1479-1487. doi: 10.1021/acs.nanolett.8b04017. Epub 2019 Feb 7. PubMed PMID:
30707035; PubMed Central PMCID:
PMC6417971.
Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages.
Pharm Res.
2019 Mar 11;36(4):65. doi: 10.1007/s11095-019-2596-5. PubMed PMID:
30859335; PubMed Central PMCID:
PMC6622458.
Multiplex Three-Dimensional Mapping of Macromolecular Drug Distribution in the Tumor Microenvironment.
Mol Cancer Ther.
2019 Jan;18(1):213-226. doi: 10.1158/1535-7163.MCT-18-0554. Epub 2018 Oct 15. PubMed PMID:
30322947; PubMed Central PMCID:
PMC6318001.
Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins.
Small.
2018 Dec;14(50):e1803601. doi: 10.1002/smll.201803601. Epub 2018 Nov 9. PubMed PMID:
30411856; PubMed Central PMCID:
PMC6361670.
Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors.
Biomaterials.
2018 Oct;180:206-224. doi: 10.1016/j.biomaterials.2018.07.024. Epub 2018 Jul 18. PubMed PMID:
30048910; PubMed Central PMCID:
PMC6076859.
Radiation-enhanced delivery of plasmid DNA to tumors utilizing a novel PEI polyplex.
Cancer Gene Ther.
2018 Aug;25(7-8):196-206. doi: 10.1038/s41417-017-0004-z. Epub 2017 Dec 19. PubMed PMID:
29255216; PubMed Central PMCID:
PMC6008165.
Quantitative Assessment of Nanoparticle Biodistribution by Fluorescence Imaging, Revisited.
ACS Nano.
2018 Jul 24;12(7):6458-6468. doi: 10.1021/acsnano.8b02881. Epub 2018 Jul 2. PubMed PMID:
29920064; PubMed Central PMCID:
PMC6105334.
Recent advances in nanomedicine for sepsis treatment.
Ther Deliv.
2018 May 1;9(6):435-450. doi: 10.4155/tde-2018-0009. Review. PubMed PMID:
29722636; PubMed Central PMCID:
PMC5994832.
A Comparative In Vivo Study of Albumin-Coated Paclitaxel Nanocrystals and Abraxane.
Small.
2018 Apr;14(16):e1703670. doi: 10.1002/smll.201703670. Epub 2018 Mar 23. PubMed PMID:
29570231; PubMed Central PMCID:
PMC5908729.
Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.
AAPS PharmSciTech.
2018 Feb;19(2):693-699. doi: 10.1208/s12249-017-0877-z. Epub 2017 Oct 2. PubMed PMID:
28971370; PubMed Central PMCID:
PMC5792366.
Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals.
Mol Pharm.
2018 Jan 29;. doi: 10.1021/acs.molpharmaceut.7b00783. [Epub ahead of print] PubMed PMID:
29341617; PubMed Central PMCID:
PMC6064681.
Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
J Control Release.
2017 Dec 28;268:407-415. doi: 10.1016/j.jconrel.2017.10.037. Epub 2017 Oct 27. PubMed PMID:
29111150; PubMed Central PMCID:
PMC5722701.
Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages.
J Control Release.
2017 Dec 10;267:133-143. doi: 10.1016/j.jconrel.2017.08.007. Epub 2017 Aug 7. PubMed PMID:
28797580.
What would you like to do?